InsiderSignal.AI

InsiderSignal.ai

DGX - Quest Diagnostics Inc

Insider Sale by Prevoznik Michael E (SVP, GC)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

2 days ago, Prevoznik Michael E, serving as SVP, GC at Quest Diagnostics Inc (DGX), sold 526 shares at $207.73 per share, for a total transaction value of $109,266.00. Following this transaction, Prevoznik Michael E now holds 43,294 shares of DGX.

This sale represents a 1.00% decrease in Prevoznik Michael E's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, March 3, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, March 4, 2026, 1 day after the trade was made.

Quest Diagnostics Inc operates in the HEALTHCARE sector, specifically within the DIAGNOSTICS & RESEARCH industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Prevoznik Michael E

SVP, GC

Michael E. Prevoznik is Senior Vice President, Legal and Compliance, and General Counsel at Quest Diagnostics Inc. (DGX), a role he has held since 2003 after joining the company in 1999 as Vice President and General Counsel through the acquisition of SmithKline Beecham Clinical Laboratories (SBCL).[[1]](https://theorg.com/org/quest-diagnostics/org-chart/michael-e-prevoznik)[[2]](https://fintool.com/app/research/companies/DGX/people/michael-e-prevoznik)[[7]](https://ir.questdiagnostics.com/governance/management-team/default.aspx) In this position, he oversees legal requirements, regulatory compliance, security, and government affairs, and previously managed international diagnostic information services (2011-2017) and the clinical trials business (2011-2013).[[1]](https://theorg.com/org/quest-diagnostics/org-chart/michael-e-prevoznik)[[2]](https://fintool.com/app/research/companies/DGX/people/michael-e-prevoznik) He also serves as Vice Chair of the Quest Foundation.[[2]](https://fintool.com/app/research/companies/DGX/people/michael-e-prevoznik)[[4]](https://www.marketscreener.com/insider/MICHAEL-PREVOZNIK-A0378Q/) Prevoznik began his career as an Associate at Dechert Price & Rhoads, specializing in healthcare and corporate law, before joining SBCL in 1994 as Chief Legal Compliance Officer, advancing to Vice President roles in compliance for SmithKline Beecham Healthcare Services and the parent company, where he led global compliance activities.[[1]](https://theorg.com/org/quest-diagnostics/org-chart/michael-e-prevoznik)[[4]](https://www.marketscreener.com/insider/MICHAEL-PREVOZNIK-A0378Q/) Aged 63, he holds a bachelor's degree from the University of Notre Dame, a J.D. from the University of Pennsylvania Law School, and an M.B.A. from the University of Chicago.[[1]](https://theorg.com/org/quest-diagnostics/org-chart/michael-e-prevoznik)[[4]](https://www.marketscreener.com/insider/MICHAEL-PREVOZNIK-A0378Q/) As a corporate insider, he has engaged in recent stock transactions, including sales in 2024.[[6]](http://openinsider.com/DGX)

View full insider profile →

Trade Price

$207.73

Quantity

526

Total Value

$109,266.00

Shares Owned

43,294

Trade Date

Tuesday, March 3, 2026

2 days ago

SEC Filing Date

Wednesday, March 4, 2026

Filed 1 day after trade

HEALTHCAREDIAGNOSTICS & RESEARCH

About Quest Diagnostics Inc

Company Overview

No company information available
View news mentioning DGX

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4496954

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime